주식회사 인벤테라

{
  "address": "서울특별시 서초구",
  "ceo_name": "신태현",
  "certificate": [
    {
      "cert_number": "20200300935",
      "changes": "",
      "disclosure_date": "2020-08-13",
      "first_cert_date": "2020-08-13",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2020-08-13 ~ 2022-08-12"
    },
    {
      "cert_number": "20220713010018",
      "changes": "",
      "disclosure_date": "2022-07-13",
      "first_cert_date": "2020-08-13",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2022-08-13 ~ 2025-08-12"
    },
    {
      "cert_number": "20250820010015",
      "changes": "",
      "disclosure_date": "2025-08-20",
      "first_cert_date": "2020-08-13",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2025-08-13 ~ 2028-08-12"
    }
  ],
  "company_name": "주식회사 인벤테라",
  "corp_no": "154511-*******",
  "financials": {
    "2022": {
      "capital_stock": 117658000,
      "cost_of_sales": 0,
      "current_assets": 10482841000,
      "current_liabilities": 48590000,
      "gross_profit": 0,
      "net_income": -2785357000,
      "net_income_bs": -2785356000,
      "non_current_assets": 479936000,
      "non_current_liabilities": 177064000,
      "non_operating_expenses": 3933000,
      "non_operating_income": 119985000,
      "operating_profit": -2901409000,
      "revenue": 0,
      "sga_expenses": 2901409000,
      "total_assets": 10962777000,
      "total_equity": 10737123000,
      "total_liabilities": 225654000
    },
    "2023": {
      "capital_stock": 117658000,
      "cost_of_sales": 0,
      "current_assets": 7855808000,
      "current_liabilities": 235842000,
      "gross_profit": 0,
      "net_income": -3112700000,
      "net_income_bs": -3112699000,
      "non_current_assets": 1000129000,
      "non_current_liabilities": 555162000,
      "non_operating_expenses": 20220000,
      "non_operating_income": 382584000,
      "operating_profit": -3475064000,
      "revenue": 0,
      "sga_expenses": 3475064000,
      "total_assets": 8855938000,
      "total_equity": 8064934000,
      "total_liabilities": 791003000
    },
    "2024": {
      "capital_stock": 151144000,
      "cost_of_sales": 0,
      "current_assets": 21492701000,
      "current_liabilities": 229037000,
      "gross_profit": 0,
      "net_income": -6043225000,
      "net_income_bs": -6043226000,
      "non_current_assets": 763312000,
      "non_current_liabilities": 960588000,
      "non_operating_expenses": 21930000,
      "non_operating_income": 347534000,
      "operating_profit": -6368829000,
      "revenue": 0,
      "sga_expenses": 6368829000,
      "total_assets": 22256013000,
      "total_equity": 21066388000,
      "total_liabilities": 1189625000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "999,934,500",
      "changes": "999,934,500",
      "date": "2024-09-30"
    },
    {
      "amount": "999,934,500",
      "changes": "999,934,500",
      "date": "2024-08-30"
    },
    {
      "amount": "500,181,000",
      "changes": "500,181,000",
      "date": "2022-08-31"
    },
    {
      "amount": "3,666,000,000",
      "changes": "3,666,000,000",
      "date": "2022-05-25"
    },
    {
      "amount": "1,450,040,000",
      "changes": "1,450,040,000",
      "date": "2020-06-29"
    },
    {
      "amount": "1,450,000,000",
      "changes": "1,450,000,000",
      "date": "2020-06-29"
    }
  ],
  "main_products": "의학,약학 연구개발",
  "phone": "02-533-****",
  "years": [
    2024,
    2023,
    2022
  ]
}